Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Mar 2026 for Anika Therapeutics, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Ian McLeod: trading record in brief
Ian McLeod discloses dealings in Anika Therapeutics, Inc. to SEC (Form 4). The record holds 7 filings, for trades running from 9 March 2026 to 15 March 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 17 March 2026: a share grant, in Anika Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ian McLeod
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
1,161 shares0Common StockSEC:0001193125-26-111492:1
2,658 sharesCommon StockSEC:0001193125-26-111492:3
1,449 shares@ US$14.2049.9% of flowCommon StockSEC:0001193125-26-111492:2
781 shares@ US$14.2026.9% of flowCommon StockSEC:0001193125-26-111492:4
3,774 sharesCommon StockSEC:0001193125-26-111492:0
639 shares@ US$14.9623.2% of flowCommon StockSEC:0001193125-26-102238:1
2,197 sharesCommon StockSEC:0001193125-26-102238:0
7 of 7 declarations
